EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-2.75%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.99B
AUM Growth
+$45.8M
(+2.4%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
11.45%
Top 10 Holdings %
Top 10 Hldgs %
56.29%
Holding
416
New
63
Increased
249
Reduced
78
Closed
21
Top Buys
| 1 |
Apple
AAPL
|
$42.1M |
| 2 |
NVIDIA
NVDA
|
$37.1M |
| 3 |
Microsoft
MSFT
|
$36.3M |
| 4 |
Amazon
AMZN
|
$13M |
| 5 |
Broadcom
AVGO
|
$12.2M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$37.5M |
| 2 |
Futu Holdings
FUTU
|
$13.8M |
| 3 |
TSMC
TSM
|
$13.5M |
| 4 |
Applied Materials
AMAT
|
$7.01M |
| 5 |
Full Truck Alliance
YMM
|
$4.09M |
Sector Composition
| 1 | Technology | 40.04% |
| 2 | Consumer Discretionary | 27.82% |
| 3 | Communication Services | 8.98% |
| 4 | Healthcare | 6.75% |
| 5 | Financials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Equinix
EQIX
$75.7B
| $221K | 0.01% |
234
-54
| -19% | -$50.9K |
|
352
Altria Group
MO
$112B
| $219K | 0.01% |
+4,195
| New | +$219K |
|
353
Travere Therapeutics
TVTX
$1.93B
| $217K | 0.01% |
+12,481
| New | +$217K |
|
354
IDEAYA Biosciences
IDYA
$2.38B
| $215K | 0.01% |
8,364
+267
| +3% | +$6.86K |
|
355
Intercontinental Exchange
ICE
$99.8B
| $214K | 0.01% |
+1,439
| New | +$214K |
|
356
Soleno Therapeutics
SLNO
$3.71B
| $211K | 0.01% |
+4,703
| New | +$211K |
|
357
Intellia Therapeutics
NTLA
$1.29B
| $210K | 0.01% |
18,053
+1,634
| +10% | +$19.1K |
|
358
Arcutis Biotherapeutics
ARQT
$2.06B
| $207K | 0.01% |
14,879
-2,906
| -16% | -$40.5K |
|
359
CME Group
CME
$94.4B
| $207K | 0.01% |
+892
| New | +$207K |
|
360
Trane Technologies
TT
$92.1B
| $206K | 0.01% |
557
-784
| -58% | -$290K |
|
361
MongoDB
MDB
$26.4B
| $204K | 0.01% |
+878
| New | +$204K |
|
362
Immunovant
IMVT
$2.99B
| $204K | 0.01% |
8,250
-1,539
| -16% | -$38.1K |
|
363
Denali Therapeutics
DNLI
$2.26B
| $204K | 0.01% |
9,997
+2,436
| +32% | +$49.6K |
|
364
Novavax
NVAX
$1.28B
| $204K | 0.01% |
25,340
+1,219
| +5% | +$9.8K |
|
365
Parker-Hannifin
PH
$96.1B
| $204K | 0.01% |
+320
| New | +$204K |
|
366
Duke Energy
DUK
$93.8B
| $202K | 0.01% |
+1,873
| New | +$202K |
|
367
Enphase Energy
ENPH
$5.18B
| $201K | 0.01% |
2,925
+976
| +50% | +$67K |
|
368
Acadia Pharmaceuticals
ACAD
$4.26B
| $195K | 0.01% |
10,628
-7,704
| -42% | -$141K |
|
369
Ardelyx
ARDX
$1.57B
| $192K | 0.01% |
37,827
-366
| -1% | -$1.86K |
|
|
MOMO
370
Hello Group
MOMO
$1.37B
| $190K | 0.01% |
24,678
-17,682
| -42% | -$136K |
|
371
Syndax Pharmaceuticals
SNDX
$1.47B
| $167K | 0.01% |
12,603
+1,583
| +14% | +$20.9K |
|
372
Myriad Genetics
MYGN
$615M
| $161K | 0.01% |
+11,752
| New | +$161K |
|
373
Day One Biopharmaceuticals
DAWN
$773M
| $143K | 0.01% |
+11,276
| New | +$143K |
|
374
MannKind Corp
MNKD
$1.7B
| $142K | 0.01% |
22,039
+1,828
| +9% | +$11.8K |
|
375
Rocket Pharmaceuticals
RCKT
$354M
| $139K | 0.01% |
+11,054
| New | +$139K |
|